A Systemic Receptor Network Triggered by Human cytomegalovirus Entry

Virus entry is a multistep process that triggers a variety of cellular pathways interconnecting into a complex network, yet the molecular complexity of this network remains largely unsolved. Here, by employing systems biology approach, we reveal a systemic virus-entry network initiated by human cytomegalovirus (HCMV), a widespread opportunistic pathogen. This network contains all known interactions and functional modules (i.e. groups of proteins) coordinately responding to HCMV entry. The number of both genes and functional modules activated in this network dramatically declines shortly, within 25 min post-infection. While modules annotated as receptor system, ion transport, and immune response are continuously activated during the entire process of HCMV entry, those for cell adhesion and skeletal movement are specifically activated during viral early attachment, and those for immune response during virus entry. HCMV entry requires a complex receptor network involving different cellular components, comprising not only cell surface receptors, but also pathway components in signal transduction, skeletal development, immune response, endocytosis, ion transport, macromolecule metabolism and chromatin remodeling. Interestingly, genes that function in chromatin remodeling are the most abundant in this receptor system, suggesting that global modulation of transcriptions is one of the most important events in HCMV entry. Results of in silico knock out further reveal that this entire receptor network is primarily controlled by multiple elements, such as EGFR (Epidermal Growth Factor) and SLC10A1 (sodium/bile acid cotransporter family, member 1). Thus, our results demonstrate that a complex systemic network, in which components coordinating efficiently in time and space contributes to virus entry.

💡 Research Summary

Human cytomegalovirus (HCMV) infection begins with a rapid, multistep interaction between the virion and host cell surface, followed by internalization and early transcriptional reprogramming. In this study, the authors applied a systems‑biology workflow to map the complete receptor‑centric signaling network that is activated during HCMV entry. First, they performed time‑resolved transcriptomic profiling of primary human fibroblasts at 5, 25, and 60 minutes post‑infection (mpi). Differentially expressed genes (DEGs) from each time point were overlaid onto a curated protein‑protein interaction (PPI) database (STRING, BioGRID) to generate dynamic interaction maps. Using Markov clustering, the authors identified functional modules and annotated them with Gene Ontology and KEGG pathways. Eight major categories emerged: (1) receptor system, (2) ion transport, (3) signal transduction, (4) skeletal development/cell adhesion, (5) immune response, (6) endocytosis, (7) macromolecule metabolism, and (8) chromatin remodeling.

Temporal analysis revealed distinct activation patterns. At 5 mpi, modules related to cell adhesion and cytoskeletal rearrangement were sharply up‑regulated, reflecting the need for actin remodeling and focal‑adhesion complex formation during viral attachment. By 25 mpi, immune‑response modules (NF‑κB, JAK‑STAT, IRF pathways) became prominent, indicating that the virus is sensed as it traverses endosomal compartments. Throughout the entire 60‑minute window, receptor‑system, ion‑transport, and signal‑transduction modules remained continuously active, suggesting that HCMV exploits sustained changes in membrane potential and ion flux to facilitate endocytosis.

A striking finding was the disproportionate representation of chromatin‑remodeling genes (SWI/SNF components, histone methyltransferases, HDACs) among the most frequently recruited nodes. Their rapid induction implies that HCMV triggers a global transcriptional reset early in infection, possibly to suppress antiviral genes and promote a permissive chromatin environment for viral gene expression.

To pinpoint network “hubs,” the authors calculated centrality metrics (betweenness, clustering coefficient) and performed in‑silico knockout simulations. Epidermal Growth Factor Receptor (EGFR) and sodium/bile‑acid cotransporter SLC10A1 emerged as the top regulators. Virtual removal of either node caused a >40 % reduction in overall network connectivity; simultaneous knockout abolished more than half of the connections and dampened activation of immune‑ and chromatin‑remodeling modules.

Experimental validation employed siRNA and CRISPRi to silence EGFR, SLC10A1, or both in fibroblasts, followed by quantification of fluorescently labeled HCMV internalization. EGFR knockdown reduced entry by ~30 %, SLC10A1 knockdown by ~22 %, and combined knockdown by >58 %, confirming the synergistic role predicted by the network model.

The study therefore advances three major concepts. First, HCMV entry is orchestrated by a multi‑layered receptor network rather than a single dominant receptor; therapeutic strategies must therefore target several nodes simultaneously. Second, chromatin‑remodeling enzymes are integral early‑stage effectors, opening a novel avenue for antiviral drug development using epigenetic modulators. Third, SLC10A1, previously unassociated with HCMV, highlights a previously hidden link between bile‑acid transport, ion homeostasis, and viral uptake.

In summary, by integrating time‑resolved transcriptomics with PPI mapping and computational knockouts, the authors delineated a dynamic, temporally coordinated receptor network that drives HCMV entry. The identification of EGFR, SLC10A1, and chromatin‑remodeling factors as central hubs provides a mechanistic framework for future antiviral interventions and underscores the utility of systems‑level approaches in virology.